COMMUNIQUÉS West-GlobeNewswire
![GlobalNewswire](/sites/santelog.com/www.santelog.com/themes/santelog/images/nasdacinner.png)
-
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
26/07/2024 - 14:20 -
ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
26/07/2024 - 14:30 -
OneMedNet Announces $4.6 Million Private Placement
26/07/2024 - 14:30 -
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
26/07/2024 - 14:35 -
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
26/07/2024 - 15:00 -
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
26/07/2024 - 15:00 -
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial
26/07/2024 - 15:30 -
Junshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For Toripalimab
26/07/2024 - 16:46 -
BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo
26/07/2024 - 17:15 -
eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences
26/07/2024 - 17:59 -
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2024
26/07/2024 - 18:30 -
EssilorLuxottica: Publication of the 2024 Interim Financial Report
26/07/2024 - 18:30 -
NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024
26/07/2024 - 22:01 -
vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold
26/07/2024 - 22:05 -
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024
26/07/2024 - 22:11 -
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2024 Financial Results on August 1, 2024
26/07/2024 - 22:30 -
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
25/07/2024 - 14:30 -
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function
25/07/2024 - 14:30 -
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
25/07/2024 - 14:30
Pages